SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS)

$0 None (None%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 60

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS) News Sources

Junshi Biosciences Announces FDA’s Approval of IND Application for Phase 2/3 Clinical Study of JS207 for the Neoadjuvant Treatment of NSCLC Patients

17-10-2025

yahoo.com

Junshi Biosciences Announces Acceptance of the NDA for Roconkibart (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis

05-12-2025

yahoo.com

Junshi Biosciences Presents Results from JS207 (PD-1/VEGF BsAb) Phase 2 Combo Studies and JS212 (EGFR/HER3 ADC) FIH Phase 1/2 Study at AACR 2026

20-04-2026

yahoo.com

Junshi Biosciences Announces Approval of Toripalimab NDA for the 1st-line treatment of HER2 Expressing Urothelial Carcinoma

21-05-2026

yahoo.com

Junshi Biosciences Announces Primary Endpoints Met in Final Analysis of Phase 3 Study for Perioperative Toripalimab plus Chemotherapy for Resectable Stage II-III NSCLC

27-05-2026

yahoo.com

Junshi Biosciences Enters Licensing Collaboration with Fosun Wanbang on Roconkibart (IL-17A)

02-07-2026

yahoo.com

Junshi Biosciences Announces Acceptance of the Supplemental Application for Toripalimab plus Chemotherapy as Perioperative Treatment for Resectable Stage Ⅱ-Ⅲ NSCLC

21-07-2026

yahoo.com

Junshi Biosciences Announces 2026 Interim Financial Results and Provides Corporate Updates

27-08-2026

yahoo.com

SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS) Sentiment Trend

0 25 50 75 100 62 56 60 62 63 59 60 59 17-10-2025 05-12-2025 20-04-2026 21-05-2026 27-05-2026 02-07-2026 21-07-2026 27-08-2026 #1 #2 #3 #4 #5 #6 #7 #8 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS) FAQs

toggle

What is the current price of SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS)?

The current price of SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS) is $0.


toggle

SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS) absolute price change since previous trading day?

The absolute price change of SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS) since the previous trading day is $None.


toggle

SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS) percentage price change since previous trading day?

The percentage price change of SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS) since the previous trading day is None%.


toggle

What is the most recent average sentiment score for SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS)?

The most recent average sentiment score for SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS) is 60 out of 100.


toggle

What is the most recent average sentiment for SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS)?

The most recent sentiment for SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS) is .


SEC-8K** Filing Available For SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.